Sun Pharmaceuticals Industries Ltd (SUNPHARMA) Share Price

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in Mumbai, Maharashtra. Sun Pharma was established in 1983 by Indian businessman Dilip Shanghvi. In the same year, Sun Pharma opened its first manufacturing facility for the production of tablets and capsules at Vapi, Gujarat, India. Initially, the company manufactured five psychiatry products. In 1991, Sun Pharma established its first research centre. In 1994, Sun Pharma launched its Initial Public Offer (IPO). In 1997, Sun Pharma purchased stakes in pharmaceutical companies, TDPL and MJ Pharma. In the same year, Sun Pharma completed its first international acquisition of US firm Caraco Pharmaceutical Laboratories. In 1999, Sun Pharma acquired Milmet Labs. In 2000, Sun Pharma acquired Pradeep Drug Company. In 2004, Sun Pharma acquired Phlox Pharma (India) and niche brands from Women’s First Healthcare (USA). In 2007, Sun Pharma demerged Sun Pharma Advanced Research Company (SPARC) into a separate entity. In 2008, Sun Pharma acquired Chattem Chemicals Inc, USA. In 2010, Sun Pharma acquired a controlling stake in Israel-based Taro Pharmaceuticals. In 2014, Sun Pharma acquired the Indian multinational pharmaceutical company Ranbaxy Laboratories. In 2021, Sun Pharma forayed into the nutrition bar segment in India with the launch of Revital NXT. In 2022, Sun Pharma acquired Uractiv portfolio from Fiterman Pharma in Romania. As of March 2023, Sun Pharma has more than 40 manufacturing facilities and provides medicines to more than 100 countries across the globe. 

Products and services 

Sun Pharma is one the world’s biggest manufacturers of generic drugs for various ailments across therapeutic areas. Sun Pharma is also dedicated to developing and researching newer high quality and affordable generic drugs. Some of the therapeutic areas that Sun Pharma produces generic drugs for are respiratory diseases, cardiovascular diseases, ophthalmology, dermatology, etc. Absorica, Cequa and Ilumya are a few of the flagship products of Sun Pharma. However, Sun Pharma is best known for being a world leader in the production and development of Active Pharmaceutical Ingredients (APIs). APIs are the building blocks which key to the production and development of pharmaceutical products. In order to develop APIs, Sun Pharma employs are a large team of scientists from across the world. Sun Pharma is also in the business of producing Over-the-Counter (OTC) products. Some of the OTC products sold by Sun Pharma are analgesics, antacids, skincare products, etc. 

Listing 

Pharma major Sun Pharma is listed on a number of Indian stock exchanges such as BSE, NSE, Madras Stock Exchange, Calcutta Stock Exchange, etc. The company is a part of multiple indices like Nifty 50, Nifty 500, S&P BSE Sensex 50 etc.